Recent Articles

Chrononutrition and the Temporal Dimension of Metabolic Health Across the Aging Lifespan

Aligning food intake with endogenous circadian rhythms improves insulin sensitivity, lipid handling, and longevity pathways independently of caloric restriction, reframing meal timing as a therapeutic target.
Read more →

March 25, 2026
Sunlight, Circadian Rhythms and Glucose Metabolism in Modern Indoor Lifestyles

Reduced natural light and irregular schedules disrupt circadian organization, altering insulin sensitivity, postprandial glucose profiles, and long‑term cardiometabolic risk in continuous‑glucose‑monitoring and longevity contexts.
Read more →

March 23, 2026
Endogenous Nitric Oxide Activation Through Pranayama as a Mechanistic Pathway to Healthy Aging

Slow nasal breathing and Bhramari pranayama enhance endogenous nitric oxide, modulating vascular tone, metabolic efficiency, and redox balance to influence aging trajectories.
Read more →

March 20, 2026
Breath as Medicine in Longevity and Metabolic Health

Conscious breathwork modulates autonomic balance, inflammation, and metabolic regulation, positioning breathing as a low-cost intervention to support resilience, longevity, and healthy aging.
Read more →

March 19, 2026
Mechanistic Promise Versus Clinical Modesty of Berberine in Fat Loss and Cardiometabolic Risk Reduction Among Adults With Metabolic Dysregulation

Berberine activates AMPK and improves metabolic markers, yet human trials show only modest fat loss far outpaced by popular “natural Ozempic” claims.
Read more →

March 18, 2026
Berberine at the Crossroads of Metabolic Health and Longevity: From “Nature’s Ozempic” Hype to Translational Opportunities in Preventive Medicine

Berberine modulates AMPK, SIRT1, and mTOR pathways to improve metabolic markers, but its longevity promise still outpaces the clinical evidence supporting it.
Read more →

March 17, 2026
The Modifiable Brain: Metabolic, Vascular, and Lifestyle Determinants of Cognitive Resilience in Aging

Cognitive decline is largely preventable through targeted lifestyle strategies that address insulin resistance, neuroinflammation, vascular dysfunction, and mitochondrial failure before symptoms emerge.
Read more →

March 16, 2026
A Brief and Potent Window: 5-MeO-DMT, Ego Dissolution, Neuroplasticity, and Its Emerging Role in Metabolic and Aging Medicine

5-MeO-DMT is a short-acting serotonergic psychedelic that may catalyze rapid psychological reset, neuroplasticity, and behavioral change with potential implications for metabolic health and aging.
Read more →

March 13, 2026
Continuous Glucose Monitoring as a Pharmacodynamic Bioassay for Identifying Suspected Counterfeit GLP-1 Receptor Agonists

Continuous glucose monitoring can reveal whether an injectable GLP-1 receptor agonist produces expected glycemic effects, serving as a practical bedside authenticity check.
Read more →

March 12, 2026
Late-Night Eating as a Circadian Metabolic Stressor and Its Implications for Aging Resilience

Late-night eating disrupts circadian metabolic rhythms, impairing insulin sensitivity, sleep architecture, and cellular repair processes, thereby accelerating biological aging and increasing cardiometabolic disease risk.
Read more →

March 11, 2026